| Posted: September 19, 2007 |
|
ULURU Inc. to Present at UBS Global Life Sciences Conference 2007
|
|
(Nanowerk News) ULURU Inc. (Amex:
ULU) announced today that Kerry P. Gray, the company's President and Chief
Executive Officer, will provide a corporate presentation at the UBS Life
Sciences Conference in New York, NY on September 25, 2007 at 8:30 a.m.
Eastern time.
|
|
Interested investors and others may also listen to the presentation,
hosted by UBS, live and by replay at http://www.ibb.ubs.com and clicking on
the link for this webcast. Access to the webcast is not password protected.
|
|
About ULURU Inc.:
|
|
ULURU Inc. is an emerging specialty pharmaceutical company focused on
the development of a portfolio of wound management, plastic surgery and
oral care products to provide patients and consumers improved clinical
outcomes through controlled delivery utilizing its innovative transmucosal
delivery system and Hydrogel Nanoparticle Aggregate technology. For further
information about ULURU Inc., please visit our website at
http://www.uluruinc.com.
|
|
This press release contains certain statements that are forward-looking
within the meaning of Section 27a of the Securities Act of 1933, as
amended, including but not limited to statements made relating to the value
of our products in the marketplaces, our ability to develop and market our
technologies, commercialization of products in the marketplace and to the
future financial performance of ULURU Inc. (the "Company"). These
statements are subject to numerous risks and uncertainties, including but
not limited to the risk factors detailed in the Company's Annual Report on
Form 10-KSB for the year ended December 31, 2006 and other reports filed by
us with the Securities and Exchange Commission.
|
